Mutational Spectrum of the Iduronate 2 Sulfatase Gene in 25 Unrelated Korean Hunter Syndrome Patients: Identification of 13 Novel Mutations

被引:20
|
作者
Kim, Chi Hwa [1 ]
Hwang, Hye Zin [1 ]
Song, Seng Mi [1 ,2 ]
Paik, Kyung Hoon [2 ]
Kwon, Eun Kyung [2 ]
Moon, Kwang Bin [2 ]
Yoon, Jeong Hyeok [3 ]
Han, Cheol Kyu [3 ]
Jin, Dong-Kyu [1 ,2 ]
机构
[1] Sungkyunkwan Univ, Samsung Biomed Res Ctr, Clin Res Ctr, Seoul, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Dept Pediat, 50 Ilwon Dong, Seoul 135710, South Korea
[3] IDRtech Inc, Res Ctr, Div Mol Modeling, Kwacheon Shi, Kyounggi Do, South Korea
关键词
mucopolysaccharidosis type II; MPS2; Hunter syndrome; IDS; mutation detection; Korean;
D O I
10.1002/humu.9128
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hunter syndrome (Mucopolysaccharidosis type II, MPS2) is an X-linked recessively inherited disease caused by a deficiency of iduronate 2 sulfatase (IDS). In this study, we investigated mutations of the IDS gene in 25 Korean Hunter syndrome patients. We identified 20 mutations, of which 13 mutations are novel; 6 small deletions (69_88delCCTCGGATCCGAAACGCAGG, 121-123delCTC, 500delA, 877_878delCA, 787delG, 1042_1049delTACAGCAA), 2 insertions (21_22insG, 683_684insC), 2 terminations (529G>T, 637A>T), and 3 missense mutations (353C>A, 779T>C, 899G>T). Moreover, using TaqI or HindIII RFLPs, we found three gene deletions. When the 20 mutations were depicted in a 3-dimensional model of IDS protein, most of the mutations were found to be at structurally critical points that could interfere with refolding of the protein, although they were located in peripheral areas. We hope that these findings will further the understanding of the underlying mechanisms associated with the disease. (c) 2003 Wiley-Liss, Inc.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Retroviral-mediated transfer of the iduronate-2-sulfatase gene into lymphocytes for treatment of mild hunter syndrome (mucopolysaccharidosis type II)
    Whitley, CB
    McIvor, RS
    Aronovich, EL
    Berry, SA
    Blazar, BR
    Burger, SR
    Kersey, JH
    King, RA
    Faras, AJ
    Latchaw, RE
    McCullough, J
    Pan, D
    Ramsay, NKC
    Stroncek, DF
    HUMAN GENE THERAPY, 1996, 7 (04) : 537 - 549
  • [42] Detection of hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: Biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers
    Lin, Shuan-Pei
    Chang, Jui-Hung
    Lee-Chen, Guey-Jen
    Lin, Dar-Shong
    Lin, Hsiang-Yu
    Chuang, Chih-Kuang
    CLINICA CHIMICA ACTA, 2006, 369 (01) : 29 - 34
  • [43] Identification of 17 novel mutations in 40 Argentinean unrelated families with mucopolysaccharidosis type II (Hunter syndrome)
    Amartino, H.
    Ceci, R.
    Masllorens, F.
    Arberas, A. Gal D. C.
    Bay, L.
    Ilari, R.
    Dipierri, J.
    Specola, N.
    Cabrera, A.
    Rozenfeld, P.
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2014, 1 : 401 - 406
  • [44] Novel and recurrent mutations in the F13A1 gene in unrelated Korean patients with congenital factor XIII deficiency
    Jang, Mi-Ae
    Park, Young Shil
    Lee, Ki-O
    Kim, Hee-Jin
    BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (01) : 46 - 49
  • [45] Mutational analysis of Sanfilippo syndrome type A (MPS IIIA): identification of 13 novel mutations
    Beesley, CE
    Young, EP
    Vellodi, A
    Winchester, BG
    JOURNAL OF MEDICAL GENETICS, 2000, 37 (09) : 704 - 707
  • [46] Characterization of a HIR-Fab-IDS, Novel Iduronate 2-Sulfatase Fusion Protein for the Treatment of Neuropathic Mucopolysaccharidosis Type II (Hunter Syndrome)
    Valentina D. Gusarova
    Maxim A. Smolov
    Ivan V. Lyagoskin
    Maksim B. Degterev
    Elizaveta V. Rechetnik
    Alexander V. Rodionov
    Marina S. Pantyushenko
    Rahim R. Shukurov
    BioDrugs, 2023, 37 : 375 - 395
  • [47] Characterization of a HIR-Fab-IDS, Novel Iduronate 2-Sulfatase Fusion Protein for the Treatment of Neuropathic Mucopolysaccharidosis Type II (Hunter Syndrome)
    Gusarova, Valentina D.
    Smolov, Maxim A.
    Lyagoskin, Ivan V.
    Degterev, Maksim B.
    Rechetnik, Elizaveta V.
    Rodionov, Alexander V.
    Pantyushenko, Marina S.
    Shukurov, Rahim R.
    BIODRUGS, 2023, 37 (03) : 375 - 395
  • [48] Molecular Analysis of 30 Mucopolysaccharidosis Type I Patients: Evaluation of the Mutational Spectrum in Italian Population and Identification of 13 Novel Mutations
    Venturi, N.
    Rovelli, A.
    Parini, R.
    Menni, F.
    Brambillasca, F.
    Bertagnolio, F.
    Uziel, G.
    Gatti, R.
    Filocamo, M.
    Donati, M. A.
    Biondi, A.
    Goldwurm, S.
    HUMAN MUTATION, 2002, 20 (03) : 231
  • [49] Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency
    Ayako Tabata
    Jian-Sheng Sheng
    Miharu Ushikai
    Yuan-Zong Song
    Hong-Zhi Gao
    Yao-Bang Lu
    Fumihiko Okumura
    Mikio Iijima
    Kozo Mutoh
    Shosei Kishida
    Takeyori Saheki
    Keiko Kobayashi
    Journal of Human Genetics, 2008, 53 : 534 - 545
  • [50] Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency
    Tabata, Ayako
    Sheng, Jian-Sheng
    Ushikai, Miharu
    Song, Yuan-Zong
    Gao, Hong-Zhi
    Lu, Yao-Bang
    Okumura, Fumihiko
    Iijima, Mikio
    Mutoh, Kozo
    Kishida, Shosei
    Saheki, Takeyori
    Kobayashi, Keiko
    JOURNAL OF HUMAN GENETICS, 2008, 53 (06) : 534 - 545